Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

NCT00220649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin

Sponsor

St. Luke's-Roosevelt Hospital Center

Collaborators

[object Object]